Clinical Trial Update: A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Ranquilon tablets in anxiety associated with neurasthenia and adjustment disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adjustment Disorders
• Anxiety
• Neurasthenia

Drugs mentioned

• Ranquilon

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Anxiety, Neurasthenia | Phase 3 | Status: COMPLETED